Timothy D. Moore
Impact in
Papers in
- Oncology 21
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 3
-
- DNA Repair Mechanisms 4
- Cancer therapeutics and mechanisms 4
- Co-authors
- Carolyn Gotay (2 shared papers)Bruce D. Cheson (2 shared papers)Edward L. Korn (2 shared papers)Mary S. McCabe (1 shared paper)Robert G. Lloyd (4 shared papers)Earl B. Dawson (2 shared papers)William J. McGanity (2 shared papers)Stacy Nerenstone (1 shared paper)
- Journals
- Journal of Clinical Oncology (11 papers)American Journal of Health-System Pharmacy (10 papers)Cancer (3 papers)Investigational New Drugs (2 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesUnited KingdomMalaysia
In The Last Decade
Timothy D. Moore
52 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 145
- Oncology 798
- Genetics 240
- Otorhinolaryngology 79
- Cancer Research 238
- Pathology and Forensic Medicine 231
Countries citing papers authored by Timothy D. Moore
This map shows the geographic impact of Timothy D. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy D. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy D. Moore more than expected).
Fields of papers citing papers by Timothy D. Moore
This network shows the impact of papers produced by Timothy D. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy D. Moore. The network helps show where Timothy D. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy D. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 279 | |
| 2 | 2009 | 197 | |
| 3 | 1992 | 186 | |
| 4 | 1992 | 121 | |
| 5 | Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. | 1994 | 96 |
| 6 | 2005 | 92 | |
| 7 | 1991 | 76 | |
| 8 | 2013 | 70 | |
| 9 | 2014 | 65 | |
| 10 | 1978 | 57 | |
| 11 | 1986 | 50 | |
| 12 | 1980 | 49 | |
| 13 | 2013 | 35 | |
| 14 | 2003 | 30 | |
| 15 | 2005 | 28 | |
| 16 | The mathematical relationship of drinking water lithium and rainfall to mental hospital admission. | 1970 | 28 |
| 17 | 2016 | 26 | |
| 18 | 2014 | 23 | |
| 19 | 2008 | 21 | |
| 20 | 2003 | 20 |
About Timothy D. Moore
Timothy D. Moore is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Geriatrics and Gerontology, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Breast Cancer Treatment Studies (5 papers), DNA Repair Mechanisms (4 papers), Cancer therapeutics and mechanisms (4 papers), Bacterial Genetics and Biotechnology (4 papers), HER2/EGFR in Cancer Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (798 citations), Genetics (240 citations), Otorhinolaryngology (79 citations), Cancer Research (238 citations) and Pathology and Forensic Medicine (231 citations). Timothy D. Moore has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Carolyn Gotay, Bruce D. Cheson, Edward L. Korn, Mary S. McCabe, Robert G. Lloyd, Earl B. Dawson, William J. McGanity, Stacy Nerenstone, Kathy S. Albain and Jane I. Grove. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Health-System Pharmacy, Cancer, Investigational New Drugs and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.